Disruptive technologies are often talked about in pharma circles. But when it comes to AI, what long-term impact will it have?

A trial for a new immunotherapy is seeing incredible results for rectal cancer patients.

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

With mRNA offering more straightforward development and manufacturing processes, are the days of traditional vaccine modalities numbered?

The experts of PCI Pharma Services to school us on designing a best-in-class potent packaging suite

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

What role will CAR-Tregs play in the growing advanced therapy landscape?

To see true progress, pharma manufacturers will have to do away with their legacy systems.

Where are pharma companies falling behind when it comes to the environment?

How can smart packaging designs help boost medical adherance?